{
    "eid": "2-s2.0-85148365925",
    "title": "An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice",
    "cover-date": "2022-10-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Molecular Medicine",
            "@code": "1313",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Pharmaceutical Science",
            "@code": "3003",
            "@abbrev": "PHAR"
        },
        {
            "@_fa": "true",
            "$": "Drug Discovery",
            "@code": "3002",
            "@abbrev": "PHAR"
        }
    ],
    "keywords": [
        "Chlamydomonas reinhardtii",
        "mucosal vaccine",
        "oral vaccine boosting",
        "sterilizing immunity",
        "variant of concern"
    ],
    "authors": [
        "Dania O. Govea-Alonso",
        "Ashwini Malla",
        "Omayra C. Bola\u00f1os-Mart\u00ednez",
        "Sornkanok Vimolmangkang",
        "Sergio Rosales-Mendoza"
    ],
    "citedby-count": 2,
    "ref-count": 39,
    "ref-list": [
        "A guide to vaccinology: From basic principles to new developments",
        "Progress of the COVID-19 vaccine effort: Viruses, vaccines and variants versus efficacy, effectiveness and escape",
        "Efficacy, immunogenicity and safety of COVID-19 vaccines: A systematic review and meta-analysis",
        "COVID-19 vaccines: Rapid development, implications, challenges and future prospects",
        "Vaccines for COVID-19: The current state of play",
        "Primary, recall, and decay kinetics of SARS-CoV-2 vaccine antibody responses",
        "Advances in mRNA vaccines for infectious diseases",
        "COVID-19 vaccine: Where are we now and where should we go?",
        "Considerations for novel COVID-19 mucosal vaccine development",
        "Attacking the intruder at the gate: Prospects of mucosal anti SARS-CoV-2 vaccines",
        "Intranasal ChAdOx1 nCoV-19/AZD1222 vaccination reduces viral shedding after SARS-CoV-2 D614G challenge in preclinical models",
        "Protection of K18-hACE2 mice and ferrets against SARS-CoV-2 challenge by a single-dose mucosal immunization with a parainfluenza virus 5-based COVID-19 vaccine",
        "Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2",
        "Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA vaccine for respiratory mucosal immunization: Development and Proof-of-Principle",
        "Intranasal administration of RBD nanoparticles confers induction of mucosal and systemic immunity against SARS-CoV-2",
        "Expression of SARS-CoV-2 Spike protein receptor binding domain on recombinant B. subtilis on spore surface: A potential COVID-19 oral vaccine candidate",
        "Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccine",
        "Oral vaccination protects against severe acute respiratory syndrome coronavirus 2 in a Syrian hamster challenge model",
        "Protection against SARS-CoV-2 infection by a mucosal vaccine in rhesus macaques",
        "Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine",
        "The potential of algal biotechnology to produce antiviral compounds and biopharmaceuticals",
        "Current challenges for modern vaccines and perspectives for novel treatment alternatives",
        "Algae-based oral recombinant vaccines",
        "Algevir: An expression system for microalgae based on viral vectors",
        "Current Status and Perspective on the Use of Viral-Based Vectors in Eukaryotic Microalgae",
        "High level production of monoclonal antibodies using an optimized plant expression system",
        "Efficient transient expression of recombinant proteins using DNA viral vectors in freshwater microalgal species",
        "Chlamydomonas reinhardtii chloroplasts express an orally immunogenic protein targeting the p210 epitope implicated in atherosclerosis immunotherapies",
        "Low-dose oral immunization with lyophilized tissue of herbicide-resistant lettuce expressing hepatitis B surface antigen for prototype plant-derived vaccine tablet formulation",
        "Potential SARS-CoV-2 immune correlates of protection in infection and vaccine immunization",
        "Characterization of a mutant Escherichia coli heat-labile toxin, LT(R192G/L211A), as a safe and effective oral adjuvant",
        "Plant-made vaccines and therapeutics",
        "Safety, immunogenicity, and protection provided by unadjuvanted and adjuvanted formulations of a recombinant plant-derived virus-like particle vaccine candidate for COVID-19 in nonhuman primates",
        "Demystifying particle-based oral vaccines",
        "Plant cell-made protein antigens for induction of Oral tolerance",
        "Recombinant production of a functional SARS-CoV-2 spike receptor binding domain in the green algae Chlamydomonas reinhardtii",
        "A simple technology for generating marker-free chloroplast transformants of the green alga Chlamydomonas reinhardtii",
        "Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana"
    ],
    "affiliation": [
        {
            "affiliation-city": "San Luis Potos\u00ed",
            "@id": "60031335",
            "affilname": "Universidad Aut\u00f3noma de San Luis Potos\u00ed",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031335",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Chulalongkorn University",
        "CONACYT"
    ]
}